Genetic Analysis AS

NGM:GEAN Stock Report

Market Cap: NOK 25.2m

Genetic Analysis Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GEAN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders5,075,31510.3%
Institutions5,949,56612%
General Public7,333,25414.8%
Public Companies12,528,29825.4%
Private Companies18,496,83837.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.1%.

Top Shareholders

Top 25 shareholders own 84.3% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
22.5%
Bio-Rad Laboratories, Inc.
11,104,458NOK 5.7m16.8%no data
11.1%
Avanza Fonder AB
5,491,640NOK 2.8m-5.77%no data
6.55%
Muen Invest AS
3,235,128NOK 1.6m53.9%no data
4.86%
Lucellum AS
2,400,000NOK 1.2m28.2%no data
4.16%
Ochrino As
2,056,017NOK 1.0m63.7%no data
3.54%
S. Munkhaugen As
1,750,116NOK 892.6k0%no data
2.93%
Molver AS
1,444,673NOK 736.8k124%no data
2.88%
Biohit Oyj
1,423,840NOK 726.2k0%no data
2.67%
LJM AS
1,320,202NOK 673.3k11.4%no data
2.59%
GGS Invest AS
1,279,133NOK 652.4k0%no data
2.51%
Ole Baksaas
1,240,257NOK 632.5k19.7%no data
2.36%
Per Anton Invest As
1,167,910NOK 595.6k106%no data
2.14%
Stella Invest AS
1,059,232NOK 540.2k0%no data
2.12%
Erik Gjone
1,045,000NOK 532.9k42.2%no data
2.11%
Ronny Hermansen
1,040,200NOK 530.5k30.9%no data
2.04%
Tore Grøttum
1,006,754NOK 513.4k18.8%no data
2.02%
Kagge AS
999,367NOK 509.7k0%no data
0.93%
Nordnet Pensionsförsäkring Ab, Asset Management Arm
457,926NOK 233.5k-1.91%no data
0.87%
Jama Holding AS
429,351NOK 219.0k0%no data
0.86%
Bjelland Capital I AS
423,077NOK 215.8k0%no data
0.85%
Rolfs Holding AS
420,791NOK 214.6k0%no data
0.52%
T.K. Brøvig As
258,390NOK 131.8k0%no data
0.51%
Lemica AS
253,451NOK 129.3k0%no data
0.33%
Anne Camilla Bondesson
165,042NOK 84.2k0%no data
0.32%
Christina Casen
160,489NOK 81.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 20:45
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Genetic Analysis AS is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gediminas RuginisNorne Securities AS